AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Expands AAV gene therapy platform from inside the cell for genetic disorders
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2019 -- (Healthcare Sales & Marketing Network) -- Asklepios BioPharmaceutical, Inc. (AskBio), a fully integrated Adeno-Associated Virus... Biopharmaceuticals, Drug Delivery, Acquisitions Asklepios BioPharmaceutical, AskBio, RoverMed BioSciences
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Adenoviruses | Gene Therapy | Genetics | Marketing | Mergers and Aquisitions | Nanotechnology | Pharmaceuticals